{"id":1128,"date":"2012-11-05T14:07:11","date_gmt":"2012-11-05T19:07:11","guid":{"rendered":"http:\/\/blogs.cooperhealth.org\/sjmedicalreport\/?p=1128"},"modified":"2017-01-13T15:19:40","modified_gmt":"2017-01-13T15:19:40","slug":"cooper-heart-valve-center-is-new-jersey-leader-in-transcatheter-aortic-valve-replacement-tavr","status":"publish","type":"post","link":"https:\/\/blogs.cooperhealth.org\/sjmedicalreport\/2012\/11\/05\/cooper-heart-valve-center-is-new-jersey-leader-in-transcatheter-aortic-valve-replacement-tavr\/","title":{"rendered":"Cooper Heart Valve Center Is New Jersey Leader in Transcatheter Aortic Valve Replacement (TAVR)"},"content":{"rendered":"
\n

Offering ground-breaking technology and unmatched expertise, the Cooper Heart Valve Center<\/a> has rapidly become the top site in the state, and one of the top five commercial sites in the nation for the performance of transcatheter aortic valve replacement, TAVR.<\/p>\n

TAVR, the revolutionary percutaneous aortic valve, received FDA \u00a0approval in late 2011 for use in patients unable to undergo surgical aortic valve repair. Cooper University Hospital was one\u00a0 of \u00a0the \u00a0first sites in the \u00a0nation to offer \u00a0the innovative therapy after approval.<\/p>\n

\u201cCooper has \u00a0assembled \u00a0a \u00a0multi-disciplinary \u00a0team that is a model for sites across the nation,\u201d says Zoltan G. Turi, MD, Director of \u00a0the \u00a0Cooper TAVR \u00a0and Structural \u00a0Heart \u00a0Disease Programs. \u201cOur team includes surgeons, interventional cardiologists, echocardiographers, a radiologist, cardiac anesthesiologists, \u00a0and physician \u00a0assistants, \u00a0who work together at many stages of the process, including a joint meeting on the days we perform TAVRs to review the cases in detail.\u201d<\/p>\n

The Cooper Heart Institute also welcomes the recent expansion of TAVR indications. \u00a0The FDA \u00a0recently \u00a0extended TAVR \u00a0approval \u00a0to \u00a0include \u00a0patients at high \u00a0risk for \u00a0surgery. Previously TAVR \u00a0was \u00a0approved for \u00a0inoperable \u00a0patients only. This \u00a0broadening\u00a0\u00a0 of\u00a0 \u00a0indications \u00a0will\u00a0 \u00a0significantly\u00a0\u00a0 expand the\u00a0 \u00a0reach\u00a0 \u00a0of\u00a0 \u00a0the\u00a0 \u00a0TAVR\u00a0 \u00a0program,\u00a0 \u00a0opening \u00a0the\u00a0 \u00a0option \u00a0of percutaneous aortic valve replacement to many more patients than the current guidelines allow.<\/p>\n

Completion of the new Cooper hybrid cardiac catheterization suite will allow the growing TAVR program to move to the catheterization laboratory from its current location in the operating suites. The technological upgrades will make available\u00a0 3-D \u00a0echo \u00a0and \u00a0cardiopulmonary\u00a0 bypass \u00a0along\u00a0 with open heart capabilities in the catheterization suite.<\/p>\n

\u201cThe FDA is reportedly adding \u00a0additional \u00a0therapeutic approaches \u00a0in \u00a0late \u00a02012\u201d, \u00a0says \u00a0Frank \u00a0W. \u00a0Bowen, III, \u00a0MD<\/a>, cardiothoracic surgeon for the Cooper TAVR program. \u201cThey are likely to introduce the option of a\u00a0transapical approach for TAVR \u00a0candidates. This approach allows patients with smaller arteries to have a mini-thoracotomy to have the device placed across the aortic valve via the apex of the beating heart.\u201d<\/p>\n

TAVR is only one of the structural heart disease repair opportunities the Cooper Heart Institute\u2019s \u00a0Heart Valve Center\u00a0 has \u00a0planned for \u00a02013. \u00a0The hybrid room\u00a0capabilities will allow Cooper to offer both a novel technology\u00a0 for left atrial appendage occlusion as an option to anti- coagulant therapy in atrial fibrillation, as well as a new percutaneous mitral valve\u00a0repair technique.<\/p>\n

Ne<\/strong>w <\/strong>T<\/strong>r<\/strong>e<\/strong>a<\/strong>t<\/strong>m<\/strong>e<\/strong>n<\/strong>t<\/strong> \u00a0Option for A- Fib \u00a0Patients<\/strong><\/p>\n

A<\/strong>v<\/strong>o<\/strong>i<\/strong>di<\/strong>n<\/strong>g <\/strong>A<\/strong>n<\/strong>t<\/strong>i<\/strong>co<\/strong>a<\/strong>g<\/strong>u<\/strong>l<\/strong>a<\/strong>t<\/strong>io<\/strong>n<\/strong><\/p>\n

The Cooper \u00a0Heart Institute is the first site \u00a0in the region to offer an innovative catheter- based atrial appendage occlusion treatment option for patients with atrial fibrillation who are unable or unwilling to be anticoagulated. Unlike earlier procedures (also pioneered at Cooper) that were designed for patients who were able to take anticoagulants, the LARIAT \u2122 device is FDA approved for all patients with atrial fibrillation, whether or not they can be anticoagulated.<\/p>\n

The procedure \u00a0involves placing a suture around the neck \u00a0of the left atrial appendage, obliterating this major site of thrombus formation. Similar to a pericardial drainage procedure, the LARIAT \u2122 is advanced over a magnetic tip guidewire that allows a lasso to be placed over the atrial appendage and prevent clot formation. Unlike prior technologies, the LARIAT \u2122 leaves no device inside the heart at all.<\/p><\/blockquote>\n

Cooper University Hospital remains a Delaware Valley leader in all heart valve repair and replacement. Ranked in the top 6 percent of aortic valve repair programs nationwide by the Society of Thoracic Surgery (STS), Cooper cardiac surgeons perform 95 percent of aortic valve replacement surgeries, and two-thirds of mitral valve procedures minimally invasively. Cooper \u00a0also\u00a0 maintains \u00a0exceptional \u00a0outcome statistics \u00a0for \u00a0the \u00a0surgical mitral valve \u00a0repair \u00a0program, \u00a0reporting no mortality for mitral valve repairs in 2009, 2010, and 2011. The Cooper Heart Valve Center is a regional center of excellence for valve disease care providing comprehensive assessment \u00a0and management for aortic, mitral, pulmonic \u00a0and tricuspid disease.<\/p>\n

For \u00a0more information about TAVR, \u00a0the\u00a0 Cooper Heart Valve \u00a0Center<\/a>, or to refer a patient\u00a0 for\u00a0 \u00a0heart valve consultation, please call \u00a0856.296.6516.<\/strong><\/p>\n<\/div>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Offering ground-breaking technology and unmatched expertise, the Cooper Heart Valve Center has rapidly become the top site in the state, and one of the top five commercial sites in the nation for the performance of transcatheter aortic valve replacement, TAVR. TAVR, the revolutionary percutaneous aortic valve, received FDA \u00a0approval in late 2011 for use in … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6,55],"tags":[111,123,124,93,122,125],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-dzarnosky","4":"post-1128","6":"format-standard","7":"category-medical-education","8":"category-new-initiatives","9":"post_tag-cooper-heart-valve-center","10":"post_tag-frank-w-bowen","11":"post_tag-iii","12":"post_tag-md","13":"post_tag-tavr","14":"post_tag-zoltan-g-turi"},"_links":{"self":[{"href":"https:\/\/blogs.cooperhealth.org\/sjmedicalreport\/wp-json\/wp\/v2\/posts\/1128","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.cooperhealth.org\/sjmedicalreport\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.cooperhealth.org\/sjmedicalreport\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.cooperhealth.org\/sjmedicalreport\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.cooperhealth.org\/sjmedicalreport\/wp-json\/wp\/v2\/comments?post=1128"}],"version-history":[{"count":11,"href":"https:\/\/blogs.cooperhealth.org\/sjmedicalreport\/wp-json\/wp\/v2\/posts\/1128\/revisions"}],"predecessor-version":[{"id":1704,"href":"https:\/\/blogs.cooperhealth.org\/sjmedicalreport\/wp-json\/wp\/v2\/posts\/1128\/revisions\/1704"}],"wp:attachment":[{"href":"https:\/\/blogs.cooperhealth.org\/sjmedicalreport\/wp-json\/wp\/v2\/media?parent=1128"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.cooperhealth.org\/sjmedicalreport\/wp-json\/wp\/v2\/categories?post=1128"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.cooperhealth.org\/sjmedicalreport\/wp-json\/wp\/v2\/tags?post=1128"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}